Drug intelligence / Profile preview

Qufeng Runfan Powder

Development stage: Unknown
Lead developer: Beijing University of Chinese Medicine
Administration: Topical

Overview

Qufeng Runfan Powder is a Traditional Chinese Medicine (TCM) powder formulation under investigation for the treatment of acne vulgaris. It has been studied in a multicenter, randomized, double-blind, placebo-controlled clinical trial for its efficacy and safety in patients with acne vulgaris presenting with syndromes of dampness and blood stasis. The trial results indicated that the modified version of this powder was effective and safe for treating acne vulgaris.

Other names: Modified Qufeng Runmian PowderJiajianqufengrunmian powder加减祛风润面散祛风润面散

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Qufeng Runfan Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qufeng Runfan Powder.

Explore the full profile